If a bill in the New Jersey legislature becomes law, the state will be able to invest in local biotechnology firms, a coauthor of the bill said last week.

Senate Bill 712, which was passed Dec. 15 and is pending in the Assembly, has come under some scrutiny because it would allow the state's pension funds to invest in riskier products such as venture capital, junk bonds, and derivatives.

Subscribe Now

Access to authoritative analysis and perspective and our data-driven report series.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.